A Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

127

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

August 31, 2005

Study Completion Date

August 31, 2005

Conditions
Prostate Cancer
Interventions
DRUG

Degarelix

Drug supplied as a powder to be dissolved in the solvent for solution for injection. Maintenance dose given in twelve 28-day cycles.

Trial Locations (35)

12601

Hudson Valley Urology PC, Poughkeepsie

16801

State College Urologic Association, State College

23235

Virginia Urology Center, Richmond

27401

The Urology Center, Greensboro

33180

South Florida Medical Research, Aventura

33907

SW Florida Urological Associates, Fort Myers

34474

Florida Foundation for Healthcare Research, Ocala

35209

Urology Centers of Alabama, Homewood

46825

Northeast Indiana Research, LLC, Fort Wayne

60160

RMD Clinical Reseach Institution LLC, Melrose Park

71106

Regional Urology, Shreveport

76508

Scott & White Memorial Hospital, Temple

78229

Urology San Antonio Research, San Antonio

80210

Urology Associate PC, Denver

82001

Wyoming Research Foundation, Cheyenne

89511

Nevada Urology Associates, Reno

90404

Pacific Clinical Research, Santa Monica

90505

Western Clinical Research, Torrance

91356

West Coast Clinical Research, Tarzana

92653

South Orange County Medical Research Cnter, Laguna Woods

92801

Advanced Urology Medical Center, Anaheim

98166

Office of Jeffrey Frankel, Seattle

99508

Alaska Clinical Research Center, LLC, Anchorage

08648

Lawrenceville Urology, Lawrenceville

02904

Univeristy Urological Research Institute, Providence

05403

University of Vermont, Dept of Surgery, South Burlington

V1Y2H4

Southern Interior Medical Research Corporation, Kelowna

V3V1N1

Dr. Cal Abdreau Research, Surrey

V8T5G1

Can-Med Clinical Research, Inc., Victoria

V8V3N1

Dr. Gary Steinhoff Clinical Research, Victoria

B4N4K9

Valley Professional Center, Kentville

L4M7G1

The Male and Female Health and Research Centers, Barrie

N3R4N3

Brantford Urology Research, Brantford

L7N3V2

Burlington Professional Care, Burlington

L6H3P1

The Female/Male Health Centres, Oakville

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY